New Zealand · Delayed Price · Currency is NZD Rua Bioscience Statistics
Total Valuation
Rua Bioscience has a market cap or net worth of NZD 12.90 million. The enterprise value is 14.12 million.
| Market Cap | 12.90M |
| Enterprise Value | 14.12M |
Important Dates
The last earnings date was Thursday, September 3, 2026.
| Earnings Date | Sep 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Rua Bioscience has 339.44 million shares outstanding.
| Current Share Class | 339.44M |
| Shares Outstanding | 339.44M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +32.54% |
| Owned by Insiders (%) | 27.27% |
| Owned by Institutions (%) | 2.49% |
| Float | 222.81M |
Valuation Ratios
The trailing PE ratio is 3.80.
| PE Ratio | 3.80 |
| Forward PE | n/a |
| PS Ratio | 4.41 |
| PB Ratio | 3.03 |
| P/TBV Ratio | 6.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.08 |
| Quick Ratio | 0.37 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.59 |
| Interest Coverage | -9.54 |
Financial Efficiency
Return on equity (ROE) is -73.47% and return on invested capital (ROIC) is -32.30%.
| Return on Equity (ROE) | -73.47% |
| Return on Assets (ROA) | -27.09% |
| Return on Invested Capital (ROIC) | -32.30% |
| Return on Capital Employed (ROCE) | -70.67% |
| Weighted Average Cost of Capital (WACC) | 7.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 30 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.92% in the last 52 weeks. The beta is 0.52, so Rua Bioscience's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -26.92% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 59.69 |
| Average Volume (20 Days) | 41,545 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rua Bioscience had revenue of NZD 2.92 million and -3.36 million in losses.
| Revenue | 2.92M |
| Gross Profit | 1.16M |
| Operating Income | -3.02M |
| Pretax Income | -3.36M |
| Net Income | -3.36M |
| EBITDA | -2.63M |
| EBIT | -3.02M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 533,698 in cash and 1.76 million in debt, with a net cash position of -1.22 million or -0.00 per share.
| Cash & Cash Equivalents | 533,698 |
| Total Debt | 1.76M |
| Net Cash | -1.22M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 4.25M |
| Book Value Per Share | n/a |
| Working Capital | 236,542 |
Cash Flow
In the last 12 months, operating cash flow was -2.96 million and capital expenditures -1,515, giving a free cash flow of -2.96 million.
| Operating Cash Flow | -2.96M |
| Capital Expenditures | -1,515 |
| Depreciation & Amortization | 396,637 |
| Net Borrowing | 724,997 |
| Free Cash Flow | -2.96M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 39.80%, with operating and profit margins of -103.43% and -114.89%.
| Gross Margin | 39.80% |
| Operating Margin | -103.43% |
| Pretax Margin | -114.89% |
| Profit Margin | -114.89% |
| EBITDA Margin | -89.87% |
| EBIT Margin | -103.43% |
| FCF Margin | n/a |
Dividends & Yields
Rua Bioscience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -26.05% |
| FCF Yield | -22.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |